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The quality of life of hemodialysis and transplant patients. This study
demonstrates the application of a more comprehensive methodology for
evaluating quality of life of hemodialysis and transplant patients and
provides some heuristic data. Physiologic and psychologic measures
were combined to assess the quality of life of 59 patients treated for
endstage renal disease (ESRD). Patients with successful cadaveric
transplants gave evidence of greater physical and occupational rehabili-
tation than patients on chronic hemodialysis. On measures of subjective
quality of life, however, successful transplant and hemodialysis patients
were similar in reporting normal affect whereas failed transplant pa-
tients showed a diminished quality of life. These results suggest that
cadaveric transplantation may have limited value as an intervention to
improve quality of life for patients with ESRD. Moreover, the results
demonstrate the usefulness of questionnaire techniques adapted from
psychological research for evaluating the quality of life of patients
following medical intervention.
La qualite de Ia vie des malades hémodialysés et transplantes. Cette
étude démontre l'application d'une methodologie plus globale pour
évaluer Ia qualité de Ia vie chez des malades hémodialyses et trans-
plantés et apporte des données heuristiques. Des mesures physiolo-
giques et psychologiques ont été combinées afin d'apprecier la qualité de
Ia vie chez 59 malades traités pour une néphropathie au stade terminal
(ESRD). Les malades ayant une transplantation réussie avec un rein de
cadavre donnaient l'impression d'une meilleure rehabilitation physique
et occupationnelle que les malades en hémodialyse chronique. Cepen-
dant, par des mesures de Ia qualitC subjective de Ia vie, les malades
après transplantation réussie ou en hemodialyse étaient identiques avec
un affect normal, alors que les malades ayant un Cchec de transplanta-
tion avaient une diminution de Ia qualitC de Ia vie. Ces résultats
suggCrent que la transplantation avec un rein de cadavre pourrait avoir
une valeur limitée pour améliorer Ia qualité de la vie chez les malades
ayant une ESRD. En plus, ces résultats dCmontrent l'utilité de tech-
niques par questionnaires adaptés de Ia recherche psychologique pour
évaluer La qualite de Ia vie chez des sujets apres intervention mCdicale.
Recently, it was pointed out that evaluation of the billion-
dollar endstage renal disease (ESRD) program is long overdue
in an era of competing priorities and limited resources [1].
Studies of patient survival have indicated that maintenance
dialysis can significantly prolong the life of patients with
irreversible kidney failure [2—5], but questions have been raised
about the quality of the life thus prolonged [2, 6—121. Despite
concern about the quality of life on chronic maintenance
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dialysis, there are only a few studies that go beyond duration of
patient survival to examine the physical and occupational
rehabilitation of ESRD patients [2, 12—141. The most recent of
these studies [2] indicated that only 60% of nondiabetic patients
on hemodialysis are capable of physical activity beyond caring
for themselves and even fewer are able to work outside the
home. Even data on physical morbidity and occupational
rehabilitation are far short of what is needed to assess the
quality of life of ESRD patients, however. Measures of a
patient's sexual performance [9, 15], sleeping habits, avoca-
tions and sports, friendship and family relations, and, above all,
a patient's feelings about his life must all be included in any
comprehensive assessment of the quality of life after medical
intervention.
The available data are limited in another important way.
Studies of the quality of life on maintenance hemodialysis are
not particularly usefUl for policy decisions about the ESRD
program when no alternative treatment is examined. There is,
of course, an alternative to maintenance hemodialysis —renal
transplantation — and we believe that studies of the quality of
life of ESRD patients will be interpreted more easily and more
germane to policy if both dialysis and transplant patients are
compared in the same study [16]. The mortality data for renal
transplantation make the comparison of transplantation and
hemodialysis particularly pointed. Overall annual mortality in
large dialysis programs ranges from 8 to 15% and can go as low
as 2% in young adults free of extrarenal disease [4, 5, 14, 171.
One year mortality rates for first transplants are 10 to 15% if the
transplant comes from a parent or sibling of the patient, but are
as high as 30% for cadaveric transplantation [4, 5, 17—19]. It is
likely that these figures, the last available from National Regis-
try data, do not reflect the results currently obtainable in
leading centers [201. Indeed, with the recent developments in D-
locus matching [211 and pretransplant transfusions [22, 231,
improved survival rates for both grafts and patients have been
reported [23—25]. Cadaveric transplantation remains, however,
an elective procedure with a substantial failure rate [261 and a
first year mortality rate greater than or equal to that of
maintenance hemodialysis [27]. Moreover, there are no data
clearly establishing improved long-term survival after success-
ful cadaveric transplantation [23—26].
These observations raise the question of why many patients
elect cadaveric transplantation. Here we come again to concern
with the quality of life. A major concern of patients and
physicians is that the life of dialysis patients is impoverished
and restricted [5—8, 16, 26]; it appears probable that quality of
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Table 1. Causes of renal failure for all patients studied
Etiology
Patient group































Total 19 10 20 10 59
life may be improved by release from dependence on the
artificial kidney machine and by the more complete correction
of uremia following successful transplantation [18, 26]. Thus, it
has been argued that the cadaveric transplant morbidity and
mortality rates are more than balanced by the improved quality
of life experienced by those whose transplants succeed [25, 28].
Clearly, this argument cannot be evaluated without data that
compare cadaveric transplant recipients and hemodialysis pa-
tients on the same measures of quality of life.
The purpose of this study is to begin providing data needed
and to demonstrate a questionnaire methodology for assessing
quality of life after medical intervention. Questionnaire mea-
sures have the advantage that they can be adapted to large-
scale, multicenter studies. The study examines four groups of
patients: chronic hemodialysis patients, patients on chronic
hemodialysis awaiting cadaveric transplantation, patients with
successful cadaveric transplants, and patients back on mainte-
nance hemodialysis after failure of a cadaveric graft. The study
is far from comprehensive in that the patients are an ad hoc
sample accessible to the authors and so cannot be said to
represent the approximately 55,000 Americans on maintenance
dialysis nor the approximately 12,000 Americans who have
received cadaveric transplantation [17—191. In another way,
however, the study was reasonably comprehensive. We believe
that we tried to measure most of the dimensions of behavior and
feeling that generally are regarded as relevant to the quality of
life. In particular, we sought to strengthen our clinical data base
by using measures of known reliability and validity taken from
social psychological research on the quality of life.
Methods
The original subject pool included every patient with a
dialysis chart available at Walter Reed Army Medical Center
(WRAMC) who met the following criteria: (I) Patient must be
between 18 and 55 years of age; (2) patient must have endstage
renal disease of sufficient severity to require treatment with
either hemodialysis or transplantation; (3) if he is a transplant
patient, he must have been transplanted with a cadaveric graft
(prior transplantation with either a living-related or cadaveric
graft does not exclude patient from the study); (4) if patient has
failed tranplantation and is currently on hemodialysis, his most
recent transplantation must have been cadaveric; (5) patient
must be clinically stable: A patient hospitalized within the past
3 months for intercurrent problem or problems related either to
hemodialysis or transplantation is not eligible. All patients were
initiated on hemodialysis at WRAMC and subsequently re-
ceived chronic hemodialysis at centers close to their homes,
primarily located throughout the southeastern United States.
All transplanted patients received their grafts at WRAMC.
Standard immunosuppressive regimes were used and graft and
patient survival are comparable to national results [291.
Each patient who met the above criteria was then categorized
according to present status: (1) patients maintained on chronic
hemodialysis (chronicity defined as at least 6 months of contin-
uous hemodialysis treatment) who do not anticipate transplan-
tation due to immunologic or other medical problems, or to
personal preference; (2) patients maintained on chronic hemodi-
alysis who are awaiting cadaveric transplantation; (3) patients
who have been transplanted successfully with a cadaveric graft
(successful transplantation being defined as a functioning graft 6
months post-transplantation without overt evidence of active
chronic rejection); and (4) patients with failed cadaveric trans-
plants (defined as having had graft function for at least 1 month
before returning to hemodialysis and having been back on
hemodialysis for at least 6 months).
Questionnaires were mailed to every eligible patient for
whom an address was available. The return rates were 76, 92,
80, and 91% for groups 1 through 4, respectively. The question-
naires of two respondents were dropped from the study (one
because of superimposed acute illness of the respondent, the
other because the respondent was transplanted before he com-
pleted the questionnaire). The questionnaires of 59 patients
were included in the study, ten each from groups 2 and 4, 19
from group 1, and 20 from group 3. Objective data were taken
from the medical records and dialysis records of each
respondent.
The questionnaire first asked about demographic characteris-
tics of the respondents such as age, sex, and marital status.
Next, the questionnaire asked about behaviors and feelings
relevant to the patient's quality of life. Some of these questions
came from previous research and require elucidation. As listed
in Table 4, the seven variables (five items and two composite
scales) beginning with Satisfaction with Marriage are taken
from The Quality of American Life [301. The first three of seven
are items questioning satisfaction with marriage, satisfaction
with children, and overall life satisfaction. The next two items
are bipolar adjective pairs concerning feelings about present
life. Eight more such bipolar items (not separately presented
here) are averaged to form the Index of General Affect (next in
Table 4). Finally, the overall life-satisfaction item and the Index
of General Affect are averaged with a weighted average to form
the Index of Well-being.
The next three variables in Table 4 are also composite scales,
this time taken from The Structure of Psychological Well-Being
[311. The Positive Feelings Scale is the sum of five questions
each asking whether or not, during the past few weeks, the
respondent felt (for example) "excited or interested in some-
thing" or "pleased about having accomplished something."
Similarly, the Negative Feelings Scale sums across five ques-
tions asking whether or not the respondent had felt (for exam-
ple) "lonely or remote from other people" or "bored." The
Affect Balance Scale is then a transformation of the differences
in intensity of the previous two scales. Listed last in Table 4 are
two variables that reflect questions about the present occupa-
tional status of the respondents.


















Means are presented with sn in parentheses. No. medications indicates total number of different prescribed medicines taken on a regular basis.
Clinic visits reflect outpatient visits exclusive of dialysis treatment. Prescription frequency indicates the number of times per day patients are
required to take prescribed medicines.
b Characteristic differs across groups, P < 0.01, by one-way ANOVA or by x2.
Mean is different from transplant mean, P < 0.05, by Scheffé test.
Mean is different from three means, P < 0.05, by Scheffé test.
numbers of friends and relatives they had talked to yesterday
and during the previous months. These social network mea-
sures showed no differences across patient groups in this study
and will not be discussed further. The last part of the question-
naire was a copy of the Social Readjustment Rating Scale
(SRRS) devised by Holmes and Rahe [32], and patients were
asked to indicate what life changes they had experienced since
kidney failure. The SRRS proved to be too long or difficult for
many patients to persevere unaided; the data obtained did not
show any differences across the patient groups. This measure
also will not be discussed further in this report.
For all variables studied—medical and demographic charac-
teristics and quality of life reports—group differences were
tested for significance at the level of P < 0.01. This more
stringent than usual level is desirable to control type I error rate
for the whole study because of the large number of variables
examined. Within an overall significant effect of groups, pairs of
group means were tested for differences by Scheffé test (Tables
2 and 3) or by Student's t test of regression weights on variables
representing group membership (Table 4). By testing pairs of
means only within a significant overall group's effect, these
tests too are protected against inflation of type I error.
Results
A number of objective measures of medical status were not
significantly different across groups and are here presented as
mean SD for combined groups. For all patients together, time
since renal failure was 67 45 months. Systolic blood pressure
was 136.3 23 mm Hg, and diastolic blood pressure was 74.2
10.7 mm Hg. For all patients on dialysis (groups 1, 2, and 4):
Interdialysis weight gain was 4.45 2.23 Ibs; hours dialysis!
week, 12.9 2.31; days dialysis/week, 2.95 0.16; hematocrit,
23.8 4.14; serum albumin, 3.6 .45 g!%; predialysis serum
creatinine, 14.6 5.21 mg%; predialysis BUN, 79,8 26.7
mg%; predialysis calcium, 9.43 0.78 mg%; predialysis P04,
5.42 1.75 mg%; predialysis bicarbonate, 18.3 3.74 mEq!
liter; predialysis potassium, 5.48 0.73 mEq/liter; and body
weight, 138.6 27.2 lbs. For the successful transplant group
(group 3), time from transplant was 46 45 months (range, 6 to
195 months); serum creatinine, 1.7 0.7 mg%; BUN, 21.05
10.7 mg%; and weight gain since transplantation was 13.4
10.7 lbs. For the failed transplant group, time from graft failure
was 21.3 18.3 months (range, 6 to 56 months) and interval
from graft placement until return to dialysis was 4.51 3.2
months (range, ito 11 months). The etiology of renal failure for
members of each group is indicated in Table 1.
Some of the characteristics of medical treatment for the four
groups are presented in Table 2. The results indicate that the
pretransplant and failed transplant patients took significantly
more medications than the transplant group, that the chronic
dialysis group had a higher prescription frequency than the
transplant group, and also that the failed transplant group spent
more days in the hospital in the previous 12 months than did the
other three groups.
The demographic characteristics of our groups are listed in
Table 3, and only two variables showed a significant difference
across groups. The chronic dialysis group was older than the
transplant group and resided in smaller communities than the
failed transplant group.
The major focus of the study is the quality of life information
288 Johnson et a!
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Number children in home
Number children living
Family income (I  15K; 3  30K)
Years formal education
Percent employed before renal failure 53
Percent professional/managerial 42 20
a Characteristic differs across groups, P < 0.01,
ANOVA.
"Means are different, P < 0.05, by Scheffé test.
for our four groups presented in Table 4. Rather than analyzing
the quality of life data by one-way analysis of variance, as was
done for the medical and demographic characteristics, we used
a multiple regression approach in which group membership was
coded by dummy variables. The regression analysis is function-
ally the same as a one-way ANOVA [331 but offers the
advantage of making it possible to examine the variance ac-
counted for by group membership with a number of background
variables statistically controlled. (Data on occupational status
do not have a metric and so cannot be subjected to regression
analysis. These data are presented in percents at the bottom of
Table 4 and were analyzed by x2 test.)
Table 4 indicates that, compared to the other three groups,
the successful transplant patients were less tired, spent fewer
hours per week obtaining medical care, had a higher income
since renal failure, and the patients in the group were more
often in fulitime employment or housework. Further, the pa-
tients in the successful transplant group felt their present life
easier and less tied down than did the patients in other groups.
It is noteworthy in Table 4 that the failed transplant patients are
the most unfortunate. In comparison to the successful trans-
plant patients, the failed transplant patients spent more days in
hospital in the previous 12 months, had lower means on the
Index of General Affect and the Index of Well-being, had fewer
positive feelings during the past weeks, and had lower means on
the Affect Balance Scale.
It is interesting to compare the data for our groups of patients
with national norms for the quality of life variables taken from
Discussion
The one previous study comparing successful transplant and
dialysis patients [16] found no difference in rehabilitation be-
tween the two groups, but a much greater sense of well-being
for the transplant group. This study was in many ways different
from ours. We examined a larger sample of patients with a
longer experience at renal failure and used a substantially
different method permitting measurement of a greater number
of variables reflecting both rehabilitation and subjective quality
of life.With our patients and procedures our results are almost
the obverse of those previously reported. Our successful trans-
plant patients were less tired, less inconvenienced by medical
treatment, more often employed full time, had better incomes
since renal failure, and felt their lives easier and less tied down.
These differences represent a better rehabilitation for transplant
patients. Yet measures of subjective quality of life, taken from
national survey studies, indicate that successful transplant
patients did not differ from untransplanted dialysis patients,
though they did differ from failed transplant patients back on
dialysis. National norms for these quality of life measures
suggest further that the successful transplant patients have a
normal quality of life, with untransplanted dialysis patients
Characteristic
Table 3. Demographic characteristics of the four groups
Patient group
2 3 4
46b 38 34h 38
32 60 45 70
84 80 50 80
2.6h 1.9 2.1 1.2
2.6 2.2 2.2 2.5
1.1 1.2 1.5 1.2
117 124 79 64




Residence (1 = city; 4 = rural)a
Grew up (I — city; 4 = rural)
Dwelling (1 = house; 3 = rooms)
Months in present neighborhood
Number of persons in home
earlier survey studies of Americans (see last column of Table 4).
These norms can be thought of as providing psychological zero
points ("normal" points) for ten of our measures. On these ten,
the successful transplant group stands out as having normal to
above normal quality of life, while the three groups on dialysis
generally have normal to below-normal quality of life. This
overview can be refined by focusing on the five composite
scales in Table 4 (Index of General Affect down to Affect
Balance Scale). Because these scales average over numbers of
items, they are our most general measures of quality of life and
(as longer tests tend to be more reliable) should be our most
sensitive measures as well. The statistical analysis reported
above showed that, on four of these five scales, the failed
transplant patients reported significantly lower quality of life
than the successful transplant patients. Taking the statistical
results together with the normative data, we can say that the
successful transplant patients report normal quality of life and
1 5 1 1 1 3 1 9 that the failed transplant patients report significantly below-
normal quality of life. The two never-transplanted groups,
2.2 1.6 1.6 2.3 though tending to below-normal quality of life, are not signifi-
cantly lower than the transplant group.
2.3 1.7 1.8 1.8 The regression analysis indicates that the group differences in
13.2 13.5 13.0 12.5 quality of life reported here are relatively powerful. The vari-
ance accounted for by group membership ranges from 19%
70 55 50 ("Feel present life free to tied down") to 55% ("Hours last
20 20 week obtaining medical care"). After controlling for demo-graphic characteristics (age. sex. marital status. present resi-
by one-way dence, community where raised, months in present neighbor-
hood, number of persons in home, number of children in home,
number of living children, and family income category), the
variance accounted for by group membership ranged from 10%
("Days in hospital in last 12 months") to 34% (Positive Feelings
Scale). It appears therefore that the group differences noted as
significant in Table 4 are to a substantial degree a function of
medical intervention as represented by group membership
rather than an artifact of group differences preceding medical
treatment for renal failure.
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Table 4. Quality of life questionnaire means and percents for the four patient groups
National
norm'Question or scale5 I 2
Tired (1 — less; 3 — more) easily than before 2.8' 2.8' 1.7 3.0'
renal failure
Days in hospital in last 12 monthsd IS 34 32 91'
Hours last week obtaining medical cared 15' 17 2 20'
Hours of sleep last night 6.9 7.3 7.0 6.5
Hours sleep on average night 7.2 6.7 7.2 7.5
Number of activities or sports given up 1.9 2.6 1.0 1.7
Income now vs. before renal failure (I = less: 3 — more)' 1.9' 1.8' 2.8 2.0
Days since last intercourse 317 246 63 169
Days since orgasm 262 146 66 295
Satisfaction with marriage (I — dissatisfied; 7 = satisfied) 5.8 6.1 4.7 5.3 6.3
Problems with children (I = none; 5 — a lot) 0.8 1.3 1.3 1.9 2.0
Satisfaction with life (I = dissatisfied; 7 — satisfied) 5.4 4.5 5.6 3.7 5.5
Feel present life (I = easy; 7 = hard)a 3.6 4.9' 3.0 5.5' 3.6
Feel present life (I — free; 7 = tied down)' 3.1' 4.6' 1.5 4.0' 2.7
Index of General Affect (I — low: 7 — high) 5.2 4.4 5.8 37f 5.7
Index of Well-being (2 = low; 15 — high)d 11.2 8.9 12.0 7.7' 11.8
Positive Feelings Scale (t) to 5)' 3.7 3.7 3.6 1.7' 3.1
Negative Feelings Scale (0 to 5) 1.8 3.4 2.0 2.8 1.6
Affect Balance Scale (I = neg; 9 -. pos)d 5.8 4.5 5.5 3.1' 5.6
Full time employment or housework (%) 42 56 70 (1.0
Part- or full-time employment or housework () 69 67 80 50
Number of cases can vary (40 to 59) because of omitted responses on questionnaire and because not every question applies to every patient.
For more detailed description of questions and scales, see text.
Norms from National survey data, please see text.
d Quality of life differs across groups, P < 0.01, by multiple regression analysis.
'Quality of life differs across groups, P <0.01, by x2.
Mean is significantly different from transplant mean at P < 0.05 t test of regression weights of dummy variables for group membership.
tending to report near-normal quality of life and only the failed
transplant patients reporting consistently and substantially be-
low normal quality of life.
The near-normal quality of life of our untransplanted dialysis
patients, though surprising, is consistent with previous observa-
tions that many patients with ESRD exhibit little evidence of
gross emotional maladjustment [10, 12] in spite of the real losses
associated with renal failure [8, 9]. It is unclear how dialysis
patients can protect affect from these real losses, but many
mechanisms are likely to be involved including denial and
accommodation. Our results do not distinguish among these or
other possibilities which together comprise the complex ques-
tion of how human beings interpret and evaluate their experi-
ence. The national studies of quality of life from which we drew
our measures [30, 31] have shown that the fit between objec-
tives and subjective experience—between life resources and
satisfaction with those resources—is often a very weak fit
indeed. We note that research on the determinants of quality of
life is in its infancy [30, 31] and that renal failure provides a
powerful natural experiment with which to contribute to this
research. We suggest that both medical practice and psycholog-
ical theory are likely to profit by joining survey methods with
clinical interviewing for more intensive study of the psychology
of adjustment to renal failure.
In contrast to the near-normal quality of life of the untrans-
planted patients is the consistent and substantially below-
normal quality of life of the failed transplant patients. This
observation leads us to note that the failed-transplant patients
are in an important sense part of the transplant group for
purposes of evaluating the success of cadaveric transplantation.
That is, the expected value of a cadaveric transplant is a
weighted average of the successful transplant group, the failed
transplant group, and those receiving a cadaveric graft who do
not survive the first year after surgery. Applying this perspec-
tive to Table 4 one finds that the ways in which successful
transplant patients are significantly more fortunate than the
untransplanted patients (groups 1 and 2) are usually the same
ways in which failed-transplant patients are most unfortunate.
Full-time employment or housework, for instance, is reported
by 70% of successful transplant patients and no failed transplant
patients. Combining these two groups, 47% of surviving trans-
plant patients are working full-time, compared to 42 and 56% of
the two groups of dialysis patients. Considering just those who
survive transplantation, therefore, the data suggest that cadav-
eric transplantation is not more desirable than maintenance
hemodialysis.
As we noted earlier, our small and nonrandom sample cannot
support strong conclusions about the value of transplantation
and dialysis across the nation. But the relative homogeneity of
our patient groups (in terms of medical and demographic
characteristics) gives us confidence that the group differences in
quality of life that we found reflect treatment effects in the
patients studied. Therefore, we believe our results are clear
enough to raise some doubt about the assumption that cadaver-
ic transplantation is an effective intervention to improve quality
of life following kidney failure; we urge the importance of larger
scale studies to examine more conclusively this assumption.
Such studies will be necessary to determine the extent to which
Patient group
3 4
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the inferences drawn in this preliminary study will have general
relevance to the larger group of Americans being treated for
endstage renal disease. A larger patient population would also
permit fuller consideration and comparison of the whole range
of treatments available today, including home hemodialysis and
continuous ambulatory peritoneal dialysis.
Lastly, we think it worth noting that the measures adapted
from survey studies of the quality of American life provided
some of the most sensitive indicators of group differences in this
study. This success argues for continued efforts to apply social
psychological research to clinical investigations, not only for
evaluating transplantation and dialysis programs, but for evalu-
ating medical interventions of many different kinds [34, 35].
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